We first investigated the SAM concentration and ATRAP protein levels in clinical liver samples and discovered that the expression of both SAM and ATRAP as downregulated in NAFLD samples, as in animal models. The gene discussed is AGTRAP; the disease is metabolic dysfunction-associated steatotic liver disease.